PropertyValue
?:abstract
  • In a December 2019 technology assessment, we reported on how machine learning could reduce the time and costs required to bring new drugs to market by finding new insights in large biomedical or health-related data sets In testifying to Congress in July 2019, we took a closer look at the chemical industry, which supports nearly 26% of the US gross domestic product, the broadest measure of goods and services produced by the nation\'s economy Crucially, our report and corresponding testimony spurred Congress to enact the Sustainable Chemistry Research and Development Act of 2019, which directed the Office of Science and Technology Policy to convene an interagency entity responsible for coordinating federal programs and activities in support of sustainable chemistry In addition to involving external experts in any one report, we have established a body of cross-sectoral, interdisciplinary science and technology policy experts to advise our team on emergent and emerging issues facing Congress and the nation
is ?:annotates of
?:creator
?:journal
  • Issues_in_Science_and_Technology
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • The Return of SCIENCE AND TECHNOLOGY ASSESSMENT FOR CONGRESS
?:type
?:who_covidence_id
  • #884359
?:year
  • 2020

Metadata

Anon_0  
expand all